We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Rtw Biotech Opportunities Ltd | LSE:RTWG | London | Ordinary Share | GG00BKTRRM22 | ORD NPV (GBP) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 116.00 | 112.00 | 120.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Trust,ex Ed,religious,charty | 4.17M | -4.76M | -0.0123 | -117.07 | 447.98M |
From Dec 2022 to Dec 2024
TIDMRTW
RNS Number : 2380O
RTW Biotech Opportunities Ltd
02 October 2023
LEI: 549300Q7EXQQH6KF7Z84
2 October 2023
RTW Biotech Opportunities Ltd
(the "Company")
Total Voting Rights
In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R the Company would like to notify the market of the following:
At the close of business on the 29 September 2023, the Company had 212,389,138 Ordinary shares in issue, of which 750,000 were held in Treasury. Therefore, the total number of voting rights in the Company was 211,639,138.
The above figure 211,639,138 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information contact:
RTW Investments, LP +44 (0)20 7959 6361 Woody Stileman, Managing Director Krisha McCune, Director, Client Service
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVREKLFLXKLZBBZ
(END) Dow Jones Newswires
October 02, 2023 02:00 ET (06:00 GMT)
1 Year Rtw Biotech Opportunities Chart |
1 Month Rtw Biotech Opportunities Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
